Fact CheckerSign in

NCT04136717Active, not recruiting

Influence of FreeO2 on Percentage of Time Within Oxygen Saturation Target Using Noninvasive Ventilation (NIV) and Continuous Positive Airway Pressure (CPAP) for Patients Admitted for AECOPD or Bariatric Surgery

Influence of Automatic Oxygen Titration Device (FreeO2) on Percentage of Time Within Oxygen Saturation Target and Induced Hypercapnia During Noninvasive Ventilation for Patients Hospitalized for an Acute Exacerbation of COPD or a Bariatric Surgery

Source: ClinicalTrials.gov · Last updated 5 Nov 2026

Brief summary (registry, in English)

The main objective is to evaluate the FreeO2 device combined with noninvasive respiratory support technique for COPD patients and postoperative bariatric surgery patients. The main hypothesis is that FreeO2 device for oxygen therapy associated with NIV or nasal high flow oxygen therapy (NHFOT) allows to reach better oxygenation and avoid hypoxemia and hyperoxia.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
10 (estimated)
First submitted
15 Oct 2019
Start date
28 Oct 2019
Primary completion date
Jul 2028
Lead sponsor
François Lellouche
Diseases
Obesity
NCT number
NCT04136717

What you commit to

  • Study type: Interventional
  • Planned participants: 10
  • From 28 Oct 2019 to the primary completion date, Jul 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Any contraindication to NIV (state requiring immediate endotracheal intubation, pneumothorax, recent esophagus surgery)
  • Refusal to consent to the study
    • 5 patient with AECOPD and 5 patient with bariatric surgery will be included.

Other illness

  • Glasgow \< 12 or agitation/delirium/dementia (limiting NIV)

Age

  • Age \< 18

Other

  • Pregnancy
  • Respiratory distress or other clinical situation requiring continuous NIV or CPAP
  • Hemodynamic instability (at the beginning of the study) (increasing doses of vasopressors or inotropes)

Who the study is looking for

  • Respiratory acidosis (pH \<= 7.35 and PaCO2 \> 45 mmHg), with or without NIV (last blood gas available during hospitalization)
  • Oxygen therapy and/or SpO2 \<90% room air (FiO2 \<= 50% or nasal cannula \<= 7 L/min to maintain SpO2 90%)
  • High flow nasal cannula with flow \<= 30 L/min
  • Patients using CPAP before the surgery (obstructive sleep apnea documented).
  • Patients with obesity hypoventilation syndrome in addition to obstructive sleep apnea can be included.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Institut universitaire de Cardiologie et de Pneumologie - Université Laval
Coordinator of this site? Confirm its status
QuébecCanadaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.